✦ LIBER ✦

Linezolid versus glycopeptide or β-lactam for treatment of Gram-positive bacterial infections: meta-analysis of randomised controlled trials

✍ Scribed by Matthew E Falagas; Ilias I Siempos; Konstantinos Z Vardakas

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

P2076 Linezolid versus a glycopeptide or

✍ Falagas, M.E.; Siempos, I.I.; Vardakas, K.Z. 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Linezolid versus vancomycin or teicoplan

✍ Jiang, H.; Tang, R.-N.; Wang, J. 📂 Article 📅 2013 🏛 Springer 🌐 English ⚖ 542 KB

P857 Clindamycin/aminoglycoside versus β

✍ M.E. Falagas; D.K. Matthaiou; E.A. Karveli; G. Peppas 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 62 KB

Moxifloxacin monotherapy versus β-lactam

✍ Mao Mao An; Zui Zou; Hui Shen; Ping Hui Gao; Yong Bing Cao; Yuan Ying Jiang 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 976 KB

Meta-analysis: randomized controlled tri

✍ M. E. FALAGAS; D. K. MATTHAIOU; E. A. KARVELI; G. PEPPAS 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 750 KB

PIN24: COST EFFECTIVENESS ANALYSIS OF LI

✍ JZ Li; RJ Willke; DA Balan; D Nathwani; H López; BE Rittenhouse; M Tavacoli; E M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 78 KB